Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

China Atrial Fibrillation Screening in Acute Ischemic Stroke Patients (CRIST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02156765
Recruitment Status : Unknown
Verified June 2014 by yongjun wang, Ministry of Science and Technology of the People´s Republic of China.
Recruitment status was:  Recruiting
First Posted : June 5, 2014
Last Update Posted : June 5, 2014
Sponsor:
Information provided by (Responsible Party):
yongjun wang, Ministry of Science and Technology of the People´s Republic of China

Brief Summary:

Three purpose of this study:

  1. Increase diagnosis rate and formulate the flow of diagnosis and treatment of AF in ischemic stroke patients;
  2. Evaluation on specificity and sensitivity of STAF score;
  3. Analyze the pathogenesis of ischemic stroke and risk factors and establish clinical database and sample database of ischemic stroke.

Condition or disease
Atrial Fibrillation Stroke

Detailed Description:

Inclusion criteria:

  1. Hospitalized patients with ischemic stroke that are diagnosed definitely;
  2. Age ≥ 18 years;
  3. Within 7 days after the onset of diseases;
  4. Signed the consent informed form.

Exclusion criteria:

  1. Patients with noncerebrovascular diseases that are diagnosed definitely;
  2. Silent cerebral infarction (CI) without symptoms and signs;
  3. Those refuse to sign the consent informed form of the study.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 3000 participants
Time Perspective: Prospective
Target Follow-Up Duration: 6 Days
Official Title: China Atrial Fibrillation Screening in Acute Ischemic Stroke Patients
Study Start Date : October 2013
Estimated Primary Completion Date : March 2015
Estimated Study Completion Date : March 2015

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Accumulated detection rate of AF [ Time Frame: 1.5 year ]
    ECG was monitored for all patients enrolled in a single center for consecutive 6 days



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Hospitalized patients with ischemic stroke that are diagnosed definitely
Criteria

Inclusion Criteria:

  1. Hospitalized patients with ischemic stroke that are diagnosed definitely;
  2. Age ≥ 18 years;
  3. Within 7 days after the onset of diseases;
  4. Signed the consent informed form.

Exclusion Criteria:

  1. Patients with noncerebrovascular diseases that are diagnosed definitely;
  2. Silent cerebral infarction (CI) without symptoms and signs;
  3. Those refuse to sign the consent informed form of the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02156765


Contacts
Layout table for location contacts
Contact: yongjun wang, doctor 13911172565 yongjunwang1962@gmail.com

Locations
Layout table for location information
China, Beijing
Beijing Stroke Association Recruiting
Beijing, Beijing, China, 100050
Contact: yongjun wang, doctoe    13911172565    yongjunwang1962@gmail.com   
Sponsors and Collaborators
yongjun wang
Investigators
Layout table for investigator information
Principal Investigator: yongjun wang, doctor Tiantan Hospital
Additional Information:

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: yongjun wang, vice president of Tiantan Hospital, Ministry of Science and Technology of the People´s Republic of China
ClinicalTrials.gov Identifier: NCT02156765    
Other Study ID Numbers: TTYY-20140410
First Posted: June 5, 2014    Key Record Dates
Last Update Posted: June 5, 2014
Last Verified: June 2014
Keywords provided by yongjun wang, Ministry of Science and Technology of the People´s Republic of China:
Atrial Fibrillation
Screening
Stroke patients
Additional relevant MeSH terms:
Layout table for MeSH terms
Stroke
Atrial Fibrillation
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Arrhythmias, Cardiac
Heart Diseases
Pathologic Processes